Synchron announced today that it completed patient enrollment in the COMMAND clinical trial for its brain-computer interface (BCI). The U.S.-based trial operating under FDA investigational device exemption (IDE) enrolled six patients in total. Synchron says it’s the first IDE awarded by the FDA to assess a permanently implanted BCI. The early feasibility study assesses safety […]
Synchron
Synchron says study backs its brain–computer interface’s safety
Synchron’s stent-like brain-computer interface is getting a boost from new clinical study results out of Australia. JAMA Neurology today published peer-reviewed, long-term safety results involving four people with severe bilateral upper-limb paralysis. Twelve months after having Synchron’s Stentrode implanted inside a blood vessel in the brain, there were no adverse events. In addition, there was […]
The top 10 medtech news trends of 2022
In this episode, your diligent team of DeviceTalkers assembled to review our top 10 medtech news trends. It’s our 2022 Newmarker’s Newsmakers! Executive Editor Chris Newmarker, Pharma Editor Brian Buntz, Managing Editor Jim Hammerand, Senior Editor Danielle Kirsh and Associate Editor Sean Whooley joined me, DeviceTalks Editorial Director Tom Salemi, for the latest DeviceTalks podcast. […]
Synchron raises $75M Series C for BCI with investments from Bill Gates, Jeff Bezos
Synchron announced today that it raised an oversubscribed $75 million Series C financing round for its brain-computer interface (BCI) technology. Gates Frontier (Bill Gates’ investment fund) and Bezos Expeditions (Jeff Bezos’ investment fund) participated in the round. ARCH Venture Partners led the funding. Reliance Digital Health, Greenoaks, Alumni Ventures,Moore Strategic Ventures and Project X also […]
Synchron to begin enrollment at UPMC for brain-computer interface trial
Synchron announced today that it started enrollment in the Command trial for its brain-computer interface (BCI) technology. The company commenced enrollment at the University of Pittsburgh in Pittsburgh, Pennsylvania. It plans for its early feasibility study to primarily assess safety while exploring quantified efficacy measures of the Synchron Stentrode. Synchron’s study, funded by the National […]
7 brain-computer interface companies you need to know
Blackrock Neurotech, BrainGate, ClearPoint Neuro, Neuralink, Synchron and more race to bring brain-computer interface (BCI) tech to market. They’re using a multitude of methods — and developing their own systems that would allow patients to control a computer with their brain. Such technology could potentially enable countless immobile people someday to control a mouse cursor, […]
Report: Elon Musk looks to invest in brain-computer interface competitor Synchron
Reuters is reporting that Elon Musk has approached his Neuralink company’s rival, Synchron, over a potential investment. Musk’s Neuralink recently fell behind Synchron in the brain-computer interface (BCI) space after the latter announced that it completed its first-in-human brain-computer interface (BCI) implant in the U.S. using an endovascular BCI approach, which does not require invasive […]
Synchron completes its first U.S. human implant of brain-computer interface rivaling Elon Musk’s Neuralink
Synchron announced today that it completed its first-in-human brain-computer interface (BCI) implant in the U.S. The procedure, performed at Mount Sinai West in New York, represents the first such implant to occur in the U.S. using an endovascular BCI approach, which does not require invasive open-brain surgery. Dr. Shahram Majidi, assistant professor of neurosurgery, neurology […]
Catheter delivery could enable better brain implants: Synchron’s neuroscience chief explains how
Synchron’s catheter delivery could make brain-computer interface technology simpler, safer and more accessible than the leading alternative: open-brain surgery. Officials at Synchron — developer of the catheter-delivered Stentrode brain-computer interface (BCI) implant — believe they’re the only BCI company tapping into blood vessels to capture signals from the brain. They say they’ve already enabled a […]
Synchron says study shows safety of its brain-computer interface implant
Four ALS patients with a Synchron Stentrode brain implant had no serious adverse events one year after their procedure, which allowed the paralyzed patients to control a computer for online shopping, banking and text communication without using their hands or voice for input. New York-based Synchron said this study demonstrated the safety of its brain-computer […]
Synchron touts first-in-human implantation for brain-computer interface
Synchron said today that it completed the first successful clinical implantation of the Stentrode neural interface technology designed to restore communication in people with severe paralysis. The Campbell, Calif.-based company said the minimally invasive neural interface technology, as part of the Synchron brain-computer interface, is in its first clinical feasibility trial. The Stentrode is an […]
